Cargando…

PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis

Background: The clinical and prognostic value of programmed death-ligand 1, PD-L1, in glioblastoma remains controversial. The present study aimed to identify the expression of PD-L1 for its prognostic value in glioblastoma. Methods: A comprehensive literature search was performed using the PubMed an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Chengcheng, Chen, Gang, Zhao, Huishan, Li, Yan, Chen, Jianxin, Zhang, Hongmei, Li, Shan, Zhao, Yuze, Chen, Feng, Li, Wenbin, Jiang, Wen G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326811/ https://www.ncbi.nlm.nih.gov/pubmed/32670884 http://dx.doi.org/10.3389/fonc.2020.01015

Ejemplares similares

The prognostic significance of PD-L1 expression in patients with glioblastoma: A meta-analysis
por: Guo, Xin, et al.
Publicado: (2022)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis
por: He, Zheng, et al.
Publicado: (2020)

The Prognostic Significance of PD1 and PDL1 Gene Expression in Lung Cancer: A Meta-Analysis
por: Chang, Chih-Hao, et al.
Publicado: (2021)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

A Retrospective Study on Spinal Dissemination of Supratentorial Glioma
por: Chen, Jianxin, et al.
Publicado: (2021)

IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
por: Zhao, Yi, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Polesel, Jerry, et al.
Publicado: (2021)

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
por: Tian, Yin, et al.
Publicado: (2023)

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review
por: Zheng, Huilan, et al.
Publicado: (2023)

Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors
por: Sun, Xiangfei, et al.
Publicado: (2021)

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
por: Lu, Ling, et al.
Publicado: (2020)

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
por: Lin, Weimin, et al.
Publicado: (2018)

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials
por: Li, Xiang, et al.
Publicado: (2021)

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy
por: He, Li-na, et al.
Publicado: (2021)

Ethanol Exposure Up-Regulates PD-L1/PD-1 Immune Checkpoint Pathway and Promotes Mammary Tumor Development
por: Xu, Wenhua, et al.
Publicado: (2022)

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy
por: Li, Lingling, et al.
Publicado: (2021)

Assessment of PD-L1 mRNA expression in gastrointestinal tumors and the response to immunotherapy
por: Qiu, Qingqing, et al.
Publicado: (2022)

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
por: Luo, YingHao, et al.
Publicado: (2023)

Primary Intracranial Leiomyosarcoma Secondary to Glioblastoma: Case Report and Literature Review
por: Zhao, Liyan, et al.
Publicado: (2021)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Genetic Variation of PD-L1 Gene Affects its Expression and Is Related to Clinical Outcome in Epithelial Ovarian Cancer
por: Sun, Haiyan, et al.
Publicado: (2022)

Bone Metastases of Glioblastoma: A Case Report and Review of the Literature
por: Zhang, Wei, et al.
Publicado: (2021)

LUM Expression and Its Prognostic Significance in Gastric Cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
por: Tian, Tian, et al.
Publicado: (2021)

Expression and prognostic significance of TCTN1 in human glioblastoma
por: Meng, Delong, et al.
Publicado: (2014)

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
por: Yang, Hui, et al.
Publicado: (2020)

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
por: Wen, Lu, et al.
Publicado: (2021)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer
por: Li, Pengping, et al.
Publicado: (2020)

Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis
por: Wu, Jinyao, et al.
Publicado: (2023)

Increased PD-1(+)Foxp3(+) γδ T cells associate with poor overall survival for patients with acute myeloid leukemia
por: Zheng, Jiamian, et al.
Publicado: (2022)

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis
por: Chen, Xiao-Jiang, et al.
Publicado: (2023)

Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
por: Li, Junhong, et al.
Publicado: (2022)

PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation
por: Xia, Wenzheng, et al.
Publicado: (2020)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma
por: Zhao, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96jpg4i9fvn95kgpi68oa699ov